Cancer Immunotherapy: Bridging Basic Research and Clinical Translation

Jan 24–27, 2027 | Beaver Run Conference Center, Breckenridge, CO, United States
Scientific Organizers: Ana Carrizosa Anderson, Drew M. Pardoll, Neta Erez, and Ivan Diaz-Padilla

  In Person
  On Demand
×

-

Jan 24–27, 2027 | Beaver Run Conference Center, Breckenridge, CO, United States

Scientific Organizers: Ana Carrizosa Anderson, Drew M. Pardoll, Neta Erez, and Ivan Diaz-Padilla

Supported by the  Directors' Fund

***Meeting program subject to change.

Available Formats:   = In Person     = On Demand
Sunday, January 24, 2027
Registration
4:00–8:00 PM
Welcome Mixer
6:00–8:00 PM
Monday, January 25, 2027
Breakfast
7:00–8:00 AM
Welcome and Keynote Address
8:00–9:00 AM
Antoni Ribas, University of California, Los Angeles
How Tumors Enable Immunotherapy
Reimagining Checkpoint Targeted Therapies
9:00–11:15 AM
Ivan Diaz-Padilla, Ipsen, Oncology Global Research & Development
Lessons from Checkpoint Blockade Trials
Andrea Cercek, Memorial Sloan Kettering Cancer Center
Neoadjuvant Checkpoint Blockade in MMRd Cancer
Drew M. Pardoll, Johns Hopkins University School of Medicine
Understanding Resistance to Checkpoint Inhibition based on Neoadjuvant Clinical Trials
Short Talk(s) Chosen from Abstracts
Coffee Break
9:30–9:50 AM
Panel Discussion: Circadian Control of Immunotherapy
11:15–12:15 PM
Poster Setup
11:15–1:00 PM
On Own for Lunch
11:15–5:00 PM
Poster Viewing
1:00–10:00 PM
Symposia Spotlight 1: Cancer-Neuroimmunology
2:30–4:30 PM
Short Talks Chosen from Abstracts
Coffee Available
4:30–5:00 PM
Biological Insights from Systems that Model Human Cancer
5:00–7:00 PM
Daniela Thommen, Netherlands Cancer Institute
Rewiring T Cells in PD1 Resistant Tumors
Neta Erez, Weizmann Institute of Science
Stromal and Immune Plasticity Shape the Metastatic Niche
Raza Ali, University of Cambridge
Systems Cancer Pathology
Short Talk(s) Chosen from Abstracts
Social Hour with Dinner
7:00–8:00 PM
Posters
7:30–10:00 PM
Tuesday, January 26, 2027
Breakfast
7:00–8:00 AM
Harnessing Innate Cells for Cancer Therapy
8:00–11:00 AM
Eric Vivier, Aix Marseille University and Innate Pharma
Harnessing NK Cells in Cancer Therapies
Lydia Lynch †, Princeton University
Targeting Innate T Cells in Cancer (MAIT , gdT, and iNKT)
Judith A. Varner, University of California, San Diego
Macrophage Directed Immunotherapies
Marco Colonna †, Washington University School of Medicine
Trem2 based Therapies in Cancer
Short Talk(s) Chosen from Abstracts
Coffee Break
9:00–9:20 AM
Poster Setup
11:00–1:00 PM
On Own for Lunch
11:00–5:00 PM
Poster Viewing
1:00–10:00 PM
Career Roundtable
3:00–4:30 PM
Coffee Available
4:30–5:00 PM
Mechanisms Shaping T Cell Differentiation in Cancer
5:00–7:00 PM
Mary Philip, Vanderbilt University Medical Center
Early CD8+ T Cell Fate Commitment in Cancer
Ana Carrizosa Anderson, Harvard Medical School
Talk Title to be Announced
Jean-Christophe Beltra, University of Basel
Cytokine-Directed Gene Programs Shaping CD8+ T Cell Differentiation in Cancer
Short Talk(s) Chosen from Abstracts
Social Hour with Dinner
7:00–8:00 PM
Posters
7:30–10:00 PM
Wednesday, January 27, 2027
Breakfast
7:00–8:00 AM
Applying Engineering and Materials Science to Cancer Immunotherapy
8:00–11:00 AM
David J. Mooney, Harvard University
Engineering T Cell Cancer Therapies
Naimish Patel †, CRISPR Therapeutics
Therapeutic Applications of CRISPR
Peter Benedict Kirk †, Immunocore
Bi-Specific T Cell Engagers (BiTes)
Jamie Spangler, Johns Hopkins University
Engineering Proteins for Immunotherapy
Short Talk(s) Chosen from Abstracts
Coffee Break
9:00–9:20 AM
On Own for Lunch
11:00–5:00 PM
Symposia Spotlight 2: Late-breaking research presentations selected from abstract submissions
2:30–4:30 PM
Short Talks Chosen from Abstracts
Coffee Available
4:30–5:00 PM
Pushing the Envelope in Cancer Vaccines: Generation and Application
5:00–6:45 PM
Yardena Samuels, Weizmann Institute of Science
Novel Mechanisms Producing Targetable Tumor Antigens
Eduardo Vilar-Sanchez, University of Texas MD Anderson Cancer Center
Cancer Vaccines for Immunoprevention
Özlem Türeci †, BioNTech
Next Generation Cancer Vaccines
Short Talk(s) Chosen from Abstracts
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
6:45–7:00 PM
Social Hour with Dinner
7:00–8:00 PM
Entertainment
8:00–11:00 PM
Cash Bar
8:00–11:00 PM
Thursday, January 28, 2027
Departure
12:00–11:59 PM

Subscribe for Updates